Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix(TM) P-15 Peptide Enhanced Bone Graft

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two back-to-back papers in Spine detailing 24-month ...
Becker's Spine Review

The most interesting spine surgery findings of 2025

From clinical outcomes to costs, here are the key discoveries in spine surgery this year: 1. A study from Plano-based Texas Back Institute found positive clinical results for patients having hybrid ...
Nasdaq

Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3

HAMILTON, ON and BOSTON, Aug. 29, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as ...
Morningstar

Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – This clinical trial is designed based on the results of an ...